The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What's the reason for this funding peak?| Labiotech.eu
Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it deter her in her quest to bring a treatment for symptoms of the menopause to the market.| Labiotech.eu
Many biotech entrepreneurs dread the possibility of investors taking control in a situation that resembles a hostile takeover. But it needn't be that way.| Labiotech.eu
Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?| Labiotech.eu
Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture.| Labiotech.eu
What's my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face.| Labiotech.eu
Those are our privacy policies, showing you how we respect your privacy and your data, so we all live in a happy and non-spammy world :)| Labiotech.eu
